WallStreetZenWallStreetZen

NASDAQ: CRNX
Crinetics Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CRNX

Based on 8 analysts offering 12 month price targets for Crinetics Pharmaceuticals Inc.
Min Forecast
$33.00-0.81%
Avg Forecast
$43.75+31.5%
Max Forecast
$50.00+50.29%

Should I buy or sell CRNX stock?

Based on 8 analysts offering ratings for Crinetics Pharmaceuticals Inc.
Strong Buy
Strong Buy
3 analysts 37.5%
Buy
5 analysts 62.5%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CRNX stock forecasts and price targets.

CRNX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-04
lockedlocked$00.00+00.00%2023-11-20
lockedlocked$00.00+00.00%2023-10-24
lockedlocked$00.00+00.00%2023-09-14
lockedlocked$00.00+00.00%2023-09-11
Baird
Top 12%
89
BuyMaintains$45.00+35.26%2023-09-11
Evercore ISI Group
Bottom 10%
10
BuyMaintains$48.00+44.27%2023-09-11
JMP Securities
Top 12%
89
BuyReiterates$43.00+29.25%2023-06-15

1 of 1

Forecast return on equity

Is CRNX forecast to generate an efficient return?
Company
N/A
Industry
-0.69%
Market
30.34%

Forecast return on assets

Is CRNX forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.29%

CRNX revenue forecast

What is CRNX's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$4.1M-13.81%
Avg 2 year Forecast
$52.2M+1,005.25%
Avg 3 year Forecast
$55.4M+1,074.08%
CRNX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CRNX revenue growth forecast

How is CRNX forecast to perform vs Biotechnology companies and vs the US market?
Company
133.37%
Industry
34.65%
Market
7.68%
CRNX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CRNX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CRNX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CRNX$33.27$43.75+31.50%Strong Buy
RCKT$25.23$54.80+117.20%Strong Buy
RYTM$36.49$36.60+0.30%Strong Buy
IBRX$3.43N/AN/A
BEAM$26.40$40.00+51.52%Buy
View Top Biotech Stocks

Crinetics Pharmaceuticals Stock Forecast FAQ

Is Crinetics Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: CRNX) stock is to Strong Buy CRNX stock.

Out of 8 analysts, 3 (37.5%) are recommending CRNX as a Strong Buy, 5 (62.5%) are recommending CRNX as a Buy, 0 (0%) are recommending CRNX as a Hold, 0 (0%) are recommending CRNX as a Sell, and 0 (0%) are recommending CRNX as a Strong Sell.

If you're new to stock investing, here's how to buy Crinetics Pharmaceuticals stock.

What is CRNX's revenue growth forecast for 2023-2025?

(NASDAQ: CRNX) Crinetics Pharmaceuticals's forecast annual revenue growth rate of 133.37% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.65%, and it is also forecast to beat the US market's average forecast revenue growth rate of 7.68%.

Crinetics Pharmaceuticals's revenue in 2023 is $4,722,000.On average, 5 Wall Street analysts forecast CRNX's revenue for 2023 to be $271,872,976, with the lowest CRNX revenue forecast at $247,157,251, and the highest CRNX revenue forecast at $309,948,552. On average, 2 Wall Street analysts forecast CRNX's revenue for 2024 to be $3,486,253,223, with the lowest CRNX revenue forecast at $166,998,143, and the highest CRNX revenue forecast at $6,805,508,303.

In 2025, CRNX is forecast to generate $3,703,350,808 in revenue, with the lowest revenue forecast at $500,994,428 and the highest revenue forecast at $12,430,673,735.

What is CRNX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: CRNX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.29%.

What is CRNX's Price Target?

According to 8 Wall Street analysts that have issued a 1 year CRNX price target, the average CRNX price target is $43.75, with the highest CRNX stock price forecast at $50.00 and the lowest CRNX stock price forecast at $33.00.

On average, Wall Street analysts predict that Crinetics Pharmaceuticals's share price could reach $43.75 by Dec 4, 2024. The average Crinetics Pharmaceuticals stock price prediction forecasts a potential upside of 31.5% from the current CRNX share price of $33.27.

What is CRNX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: CRNX) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.